Matches in Nanopublications for { ?s ?p "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP423887.RAlpCmzQ1XdRHBJTLJbbjrXDr3NvOALs6bcy8WCI6W7wI130_assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP423887.RAlpCmzQ1XdRHBJTLJbbjrXDr3NvOALs6bcy8WCI6W7wI130_provenance.
- NP614882.RAcEaqsh17u12SD86Lf0uybX6gcrW4ThxpsjrgTu0u62U130_assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP614882.RAcEaqsh17u12SD86Lf0uybX6gcrW4ThxpsjrgTu0u62U130_provenance.
- NP828562.RA1u0ihhvkOjUb8AkS3t5aKOL2PZ5nhbqEyd7Ad1Mp3zA130_assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP828562.RA1u0ihhvkOjUb8AkS3t5aKOL2PZ5nhbqEyd7Ad1Mp3zA130_provenance.
- assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP825321.RALhaBdensP5Ii33-SblVKfzas54Nf1MoGCcRPcsA_65c130_assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825321.RALhaBdensP5Ii33-SblVKfzas54Nf1MoGCcRPcsA_65c130_provenance.
- NP825322.RAsXyAD8j6K14dfymVtuM9Xn7Qtu-A5lJ8z58_-q1Mt24130_assertion description "[Production of the serine protease inhibitors (serpins) plasminogen activator inhibitor-1 (PAI-1) and protease nexin-1 (PN-1) by astrocytes may counterbalance excessive serine protease activity associated with CNS pathologies such as ischemic stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP825322.RAsXyAD8j6K14dfymVtuM9Xn7Qtu-A5lJ8z58_-q1Mt24130_provenance.